Literature DB >> 4008582

High-performance liquid chromatography of etoposide in plasma and urine.

V J Harvey, S P Joel, A Johnston, M L Slevin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4008582     DOI： 10.1016/s0378-4347(00)84674-5

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  13 in total

1.  Etoposide protein binding in cancer patients.

Authors:  B Liu; H M Earl; C J Poole; J Dunn; D J Kerr
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 2.  Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.

Authors:  J J Holthuis
Journal:  Pharm Weekbl Sci       Date:  1988-06-17

3.  The effect of dose on the bioavailability of oral etoposide.

Authors:  V J Harvey; M L Slevin; S P Joel; A Johnston; P F Wrigley
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 4.  The clinical pharmacology of etoposide and teniposide.

Authors:  P I Clark; M L Slevin
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

5.  The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation.

Authors:  M L Slevin; S P Joel; R Whomsley; K Devenport; V J Harvey; R J Osborne; P F Wrigley
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Stability of the i.v. and oral formulations of etoposide in solution.

Authors:  S P Joel; P I Clark; M L Slevin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  Pharmacological attempts to improve the bioavailability of oral etoposide.

Authors:  S P Joel; P I Clark; L Heap; L Webster; S Robbins; H Craft; M L Slevin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Instability of the anticancer agent etoposide under in vitro culture conditions.

Authors:  R M Mader; G G Steger; K Moser; H Rainer; P Krenmayr; C Dittrich
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

9.  The effect of food and concurrent chemotherapy on the bioavailability of oral etoposide.

Authors:  V J Harvey; M L Slevin; S P Joel; A Johnston; P F Wrigley
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

10.  Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide.

Authors:  Keyvan Rezaï; François Lokiec; Isabelle Grandjean; Sophie Weill; Patricia de Cremoux; Vincent Bordier; Richard Ekue; Mickael Garcia; Marie-France Poupon; Didier Decaudin
Journal:  BMC Pharmacol       Date:  2007-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.